Literature DB >> 19220999

Longitudinal construct validity of the GMFM-88 total score and goal total score and the GMFM-66 score in a 5-year follow-up study.

Annika Lundkvist Josenby1, Gun-Britt Jarnlo, Christina Gummesson, Eva Nordmark.   

Abstract

BACKGROUND: The Gross Motor Function Measure (GMFM) is the instrument most commonly used to measure gross motor function in children with cerebral palsy (CP). Different scoring options have been developed, and their measurement properties have been assessed. Limited information is available regarding longitudinal construct validity.
OBJECTIVE: The objective of this research was to study the longitudinal construct validity of 3 scoring options: the 88-item GMFM (GMFM-88) total, the GMFM-88 goal total, and the 66-item GMFM (GMFM-66).
DESIGN: A clinical measurement design was used in this study.
METHODS: Forty-one children with CP diplegia who were undergoing selective dorsal rhizotomy (SDR) were monitored with the GMFM for 5 years. The mean age at SDR was 4.4 years (range=2.5-6.6). Two subgroups for gross motor function before surgery were created according to the Gross Motor Function Classification System (GMFCS): GMFCS levels I to III and GMFCS levels IV and V. This study included results obtained before SDR and at 6, 12, and 18 months and 3 and 5 years after SDR. The effect size (ES) and the standardized response mean (SRM) were calculated.
RESULTS: At 6 months postoperatively, ES and SRM values were small (<or=0.5) for all GMFM scoring options. The GMFM-88 total and goal total scores showed large changes in ES values (range=0.8-0.9) and SRM values (range=0.9-1.3) at 12 months postoperatively, whereas the GMFM-66 scores showed lower ES values (range=0.3-0.4) and SRM values (range=0.7-0.8) for both subgroups. Later postoperatively, larger values for longitudinal construct validity were found. The ES and SRM values generally were lower for the GMFM-66 scores than for the GMFM-88 total and goal total scores. LIMITATIONS: All children underwent an extensive intervention, and changes in gross motor function were expected.
CONCLUSION: All 3 scoring options showed large longitudinal construct validity in the long-term follow-up. The GMFM-88 total and goal total scores revealed large changes in gross motor function earlier postoperatively than the GMFM-66 scores.

Entities:  

Mesh:

Year:  2009        PMID: 19220999     DOI: 10.2522/ptj.20080037

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  13 in total

1.  Design and implementation of the first randomized controlled trial of coenzyme CoQ₁₀ in children with primary mitochondrial diseases.

Authors:  Peter W Stacpoole; Ton J deGrauw; Annette S Feigenbaum; Charles Hoppel; Douglas S Kerr; Shawn E McCandless; Michael V Miles; Brian H Robinson; Peter H Tang
Journal:  Mitochondrion       Date:  2012-09-25       Impact factor: 4.160

Review 2.  Lumbosacral Dorsal Rhizotomy for Spastic Cerebral Palsy: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-07-06

3.  Daily Outpatient Physical Therapy for a Toddler With a Neurodegenerative Disease: A Case Report.

Authors:  Rachel Bican; Rachel Ferrante; Sarah Hendershot; Michelle Byars; Warren Lo; Jill C Heathcock
Journal:  Pediatr Phys Ther       Date:  2022-04-01       Impact factor: 1.452

4.  Flexed-knee gait in children with cerebral palsy: a 10-year follow-up study.

Authors:  Thierry Haumont; Chris Church; Shaun Hager; Maria Julia Cornes; Dijana Poljak; Nancy Lennon; John Henley; Daveda Taylor; Tim Niiler; Freeman Miller
Journal:  J Child Orthop       Date:  2013-06-29       Impact factor: 1.548

5.  Development of a neurologic severity scale for Aicardi Goutières Syndrome.

Authors:  Laura A Adang; Francesco Gavazzi; Abbas F Jawad; Stacy V Cusack; Kimberly Kopin; Kyle Peer; Constance Besnier; Micaela De Simone; Valentina De Giorgis; Simona Orcesi; Elisa Fazzi; Jessica Galli; Justine Shults; Adeline Vanderver
Journal:  Mol Genet Metab       Date:  2020-04-02       Impact factor: 4.797

6.  Effects of hippotherapy on gross motor function and functional performance of children with cerebral palsy.

Authors:  Eun Sook Park; Dong Wook Rha; Jung Soon Shin; Soohyeon Kim; Soojin Jung
Journal:  Yonsei Med J       Date:  2014-11       Impact factor: 2.759

7.  The Sarah evaluation scale for children and adolescents with cerebral palsy: description and results.

Authors:  Katia S Pinto; Camila G C Carvalho; Lilian Nakamoto; Luiz G N Nunes
Journal:  Braz J Phys Ther       Date:  2016-03-22       Impact factor: 3.377

8.  Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy.

Authors:  Guojun Chen; Yali Wang; Zhenyu Xu; Feng Fang; Renmei Xu; Yue Wang; Xiaoli Hu; Lixing Fan; Houqi Liu
Journal:  J Transl Med       Date:  2013-01-26       Impact factor: 5.531

9.  The effect of side-alternating vibration therapy on mobility and health outcomes in young children with mild to moderate cerebral palsy: design and rationale for the randomized controlled study.

Authors:  Alena Adaikina; Paul L Hofman; Silmara Gusso
Journal:  BMC Pediatr       Date:  2020-11-05       Impact factor: 2.125

10.  Effectiveness of instrumented gait analysis in interdisciplinary interventions on parents' perception of family-centered service and on gross motor function in children with cerebral palsy: a randomized controlled trial.

Authors:  Christina Esmann Fonvig; Helle Mätzke Rasmussen; Søren Overgaard; Anders Holsgaard-Larsen
Journal:  BMC Pediatr       Date:  2020-09-01       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.